5248042026-08-055248042026-08-052026-08-055248042026-08-052026-08-05

AmalgamatedEntityDomain1

5248042026-08-05

AmalgamatedEntityDomain1

5248042026-08-052026-08-05

AmalgamatedEntityDomain2

5248042026-08-05

AmalgamatedEntityDomain2

5248042026-08-052026-08-05

AmalgamatedEntityDomain3

5248042026-08-05

AmalgamatedEntityDomain3

xbrli:purexbrli:shares

524804

AUROBINDO PHARMA LIMITED

AUROPHARMA

NOTLISTED

INE406A01037

New

Amalgamation/ Merger

true

2026-08-05

18:30:00

2026-08-05

Eugia Pharma Specialities Limited

Transferee

Subsidiary

Turnover for FY 2025-26 - Rs.27,259.04 million

621008693

Eugia Steriles Private Limited

Transferor

Step Down Subsidiary

Turnover for FY 2025-26 - Rs.62.7 million

44250000

Eugia SEZ Private Limited

Transferor

Step Down Subsidiary

Turnover for FY 2025-26 - Rs.4,874.2 million

4000000

false

true

All three companies are engaged in the business of manufacturing injectable pharmaceutical products.

The proposed amalgamation will simplify the existing group structure by consolidating three companies carrying on substantially similar businesses into a single legal entity. The amalgamation shall lead to elimination of corporate and administrative functions and overheads, cost reduction, better treasury management, synergy benefits etc.

Others

No consideration since the proposed merger is between two wholly owned subsidiaries and their holding company.

Not applicable. The Company is not a party to the Scheme of Amalgamation and the shareholding pattern of the Company remains unchanged.

Nil